Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

China's 12th Five-Year Plan May Contain $1.5 Billion for Biopharma

publication date: Aug 10, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
The 12th Five Year Plan (2011-2015) for the biopharmaceutical industry may have over 10 billion RMB ($1.5 billion) in development support for new drugs. The plan is in final draft form and may be announced in late August, according to unnamed sources that were quoted by the 21st Century Business Herald. More details...

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...